【结 构 式】 |
【药物名称】Tolvaptan, OPC-41061 【化学名称】(±)-N-[4-(7-Chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepin-1-ylcarbonyl)-3-methylphenyl]-2-methylbenzamide 【CA登记号】150683-30-0 【 分 子 式 】C26H25ClN2O3 【 分 子 量 】448.95375 |
【开发单位】Otsuka (Originator) 【药理作用】CARDIOVASCULAR DRUGS, Heart Failure Therapy, Vasopressin V2 Antagonists |
合成路线1
5-Chloro-2-nitrobenzoic acid (I) was converted into methyl ester (II) using dimethyl sulfate and K2CO3 in acetone. The nitro group of (II) was then reduced with SnCl2 to afford aniline (III), which was protected as the p-toluenesulfonamide (IV) with tosyl chloride in pyridine. Alkylation of (IV) with ethyl 4-bromobutyrate (V) yielded diester (VI). Subsequent Dieckmann cyclization of (VI) in the presence of potassium tert-butoxide provided benzazepinone (VIIa-b) as a mixture of ethyl and methyl esters, which was decarboxylated to (VIII) by heating with HCl in AcOH. Deprotection of the tosyl group of (VIII) was carried out in hot polyphosphoric acid. The resulting benzazepinone (IX) was condensed with 2-methyl-4-nitrobenzoyl chloride (X) to give amide (XI). After reduction of the nitro group of (XI) to the corresponding aniline (XII), condensation with 2-methylbenzoyl chloride (XIII) provided diamide (XIV). Finally, ketone reduction in (XIV) by means of NaBH4 led to the target compound.
【1】 Sorbera, L.A.; Silvestre, J.S.; Castañer, J.; Bayes, M.; Tolvaptan. Drugs Fut 2002, 27, 4, 350. |
【2】 Kondo, K.; Yamashita, H.; Ogawa, H.; et al.; 7-Chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-1-benzazepine (OPC-41061): A potent, orally active nonpeptide arginine vasopressin V2 receptor antagonist. Bioorg Med Chem 1999, 7, 8, 1743. |
【3】 Yabuuchi, Y.; Kora, S.; Tanaka, M.; Miyamoto, H.; Komatsu, H.; Kondo, K.; Yamashita, H.; Tominaga, M.; Ogawa, H.; Nakaya, K. (Otsuka Pharmaceutical Co., Ltd.); Benzoheterocyclic cpds. US 5985869 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(VIIa) | 33001 | methyl 7-chloro-1-[(4-methylphenyl)sulfonyl]-5-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine-4-carboxylate | C19H18ClNO5S | 详情 | 详情 | |
(VIIb) | 33002 | ethyl 7-chloro-1-[(4-methylphenyl)sulfonyl]-5-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine-4-carboxylate | C20H20ClNO5S | 详情 | 详情 | |
(I) | 32996 | 5-chloro-2-nitrobenzoic acid | 2516-95-2 | C7H4ClNO4 | 详情 | 详情 |
(II) | 32997 | methyl 5-chloro-2-nitrobenzoate | 51282-49-6 | C8H6ClNO4 | 详情 | 详情 |
(III) | 32998 | methyl 2-amino-5-chlorobenzoate | 5202-89-1 | C8H8ClNO2 | 详情 | 详情 |
(IV) | 32999 | methyl 5-chloro-2-[[(4-methylphenyl)sulfonyl]amino]benzoate | C15H14ClNO4S | 详情 | 详情 | |
(V) | 11263 | ethyl 4-bromobutanoate; Ethyl 4-bromobutyrate | 2969-81-5 | C6H11BrO2 | 详情 | 详情 |
(VI) | 33000 | methyl 5-chloro-2-[(4-ethoxy-4-oxobutyl)[(4-methylphenyl)sulfonyl]amino]benzoate | C21H24ClNO6S | 详情 | 详情 | |
(VIII) | 33003 | 7-chloro-1-[(4-methylphenyl)sulfonyl]-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one | C17H16ClNO3S | 详情 | 详情 | |
(IX) | 33004 | 7-chloro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one | C10H10ClNO | 详情 | 详情 | |
(X) | 33005 | 2-methyl-4-nitrobenzoyl chloride | C8H6ClNO3 | 详情 | 详情 | |
(XI) | 33006 | 7-chloro-1-(2-methyl-4-nitrobenzoyl)-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one | C18H15ClN2O4 | 详情 | 详情 | |
(XII) | 33007 | 1-(4-amino-2-methylbenzoyl)-7-chloro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one | C18H17ClN2O2 | 详情 | 详情 | |
(XIII) | 14770 | 2-methylbenzoyl chloride; o-Toluoyl chloride | 933-88-0 | C8H7ClO | 详情 | 详情 |
(XIV) | 33008 | N-[4-[(7-chloro-5-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methylbenzamide | C26H23ClN2O3 | 详情 | 详情 |
合成路线2
【1】 Kondo K, Ogawa H, Yamashita H, et al.1999.7-chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoyl-amino) benzoyl]-2,3,4,5-tetrahydro-1H-1-benzazepine (OPC-41061): A potent, orally active nonpeptide arginine vasopressin V2 receptor antagonist. Bioorg Med Chem, 7: 1743~1754. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 32996 | 5-chloro-2-nitrobenzoic acid | 2516-95-2 | C7H4ClNO4 | 详情 | 详情 |
(II) | 32999 | methyl 5-chloro-2-[[(4-methylphenyl)sulfonyl]amino]benzoate | C15H14ClNO4S | 详情 | 详情 | |
(III) | 33000 | methyl 5-chloro-2-[(4-ethoxy-4-oxobutyl)[(4-methylphenyl)sulfonyl]amino]benzoate | C21H24ClNO6S | 详情 | 详情 | |
(IV) | 33003 | 7-chloro-1-[(4-methylphenyl)sulfonyl]-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one | C17H16ClNO3S | 详情 | 详情 | |
(V) | 33004 | 7-chloro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one | C10H10ClNO | 详情 | 详情 | |
(VI) | 33006 | 7-chloro-1-(2-methyl-4-nitrobenzoyl)-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one | C18H15ClN2O4 | 详情 | 详情 | |
(VII) | 33007 | 1-(4-amino-2-methylbenzoyl)-7-chloro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one | C18H17ClN2O2 | 详情 | 详情 | |
(VIII) | 33008 | N-[4-[(7-chloro-5-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methylbenzamide | C26H23ClN2O3 | 详情 | 详情 |
合成路线3
【1】 Cordero-Vargas A, Quiclet-Sire B, Zard SZ.2006.A flexible approach for the preparation of substituted benzazepines: Application to the synthesis of tolvaptan. Bioorg Med Chem, 14: 6165~6173. |
【2】 Cordero-Vargas A, Perea-Martin I, Quiclet-Sire B, et al.2004.Synthesis of substituted naphthalenes from α-tetralones generated by a xanthate radical addition-cyclisation sequence. Org Biomol Chem, 2: 3018~3025. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 67450 | S-(2-(4-chlorophenyl)-2-oxoethyl) O-ethyl carbonodithioate | C11H11ClO2S2 | 详情 | 详情 | |
(II) | 67451 | 4-(4-chlorophenyl)-1-((ethoxycarbonothioyl)thio)-4-oxobutyl pivalate | C18H23ClO4S2 | 详情 | 详情 | |
(III) | 67452 | 7-chloro-4-oxo-1,2,3,4-tetrahydronaphthalen-1-yl pivalate | C15H17ClO3 | 详情 | 详情 | |
(IV) | 67453 | (E)-7-chloro-4-(hydroxyimino)-1,2,3,4-tetrahydronaphthalen-1-yl pivalate | C15H18ClNO3 | 详情 | 详情 | |
(V) | 67454 | 3,3,7-trichloro-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-5-yl pivalate | C15H16Cl3NO3 | 详情 | 详情 | |
(VI) | 67455 | 7-chloro-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-5-yl pivalate | C15H18ClNO3 | 详情 | 详情 | |
(VII) | 67456 | 7-chloro-2,3,4,5-tetrahydro-1H-benzo[b]azepin-5-yl pivalate | C15H20ClNO2 | 详情 | 详情 | |
(VIII) | 67457 | 7-chloro-1-(2-methyl-4-nitrobenzoyl)-2,3,4,5-tetrahydro-1H-benzo[b]azepin-5-yl pivalate | C23H25ClN2O5 | 详情 | 详情 | |
(IX) | 67458 | 1-(4-amino-2-methylbenzoyl)-7-chloro-2,3,4,5-tetrahydro-1H-benzo[b]azepin-5-yl pivalate | C23H27ClN2O3 | 详情 | 详情 | |
(X) | 67459 | 7-chloro-1-(2-methyl-4-(2-methylbenzamido)benzoyl)-2,3,4,5-tetrahydro-1H-benzo[b]azepin-5-yl pivalate | C31H33ClN2O4 | 详情 | 详情 |
合成路线4
【1】 Torisawa Y, Furuta T, Nishi T, et al.2007.Aminocarbonylation route to Tolvaptan. Bioorg Med Chem Lett, 17: 6455~6458. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 33004 | 7-chloro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one | C10H10ClNO | 详情 | 详情 | |
(II) | 67460 | N-(4-bromo-3-methylphenyl)-2-methylbenzamide | C15H14BrNO | 详情 | 详情 | |
(III) | 33008 | N-[4-[(7-chloro-5-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methylbenzamide | C26H23ClN2O3 | 详情 | 详情 |
合成路线5
【1】 Yamashita H, Ohtani T, Morita S, et al.2002.Practical synthesis of both enantiomers of vasopressin V2 receptor antagonist OPC-41061 using the catalytic asymmetric hydrogenation, Heterocycles, 56: 123~128. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 33008 | N-[4-[(7-chloro-5-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methylbenzamide | C26H23ClN2O3 | 详情 | 详情 | |
(II) | 67461 | (S)-N-(4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)-3-methylphenyl)-2-methylbenzamide | C26H25ClN2O3 | 详情 | 详情 | |
(III) | 67462 | (S)-7-chloro-1-(2-methyl-4-(2-methylbenzamido)benzoyl)-2,3,4,5-tetrahydro-1H-benzo[b]azepin-5-yl benzoate | C33H29ClN2O4 | 详情 | 详情 |